Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion

Journal of Clinical Gastroenterology

Volumn 49, Issue 2, 2015, Pages 165-168

  Riveiro Barciela, Mar ^a   Mínguez, Beatriz ^a   Gironés, Rosa ^b   Rodriguez Frías, Francisco ^a   Quer, Josep ^a   Buti, María ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

acute hepatitis; hepatitis E virus; ribavirin; zoonotic transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT; BIOLOGICAL MARKER; HEPATITIS ANTIBODY;

ABSENCE OF SIDE EFFECTS; ACUTE HEPATITIS; ACUTE HEPATITIS E; AGED; ARTICLE; ASTHENIA; CASE REPORT; DETERIORATION; FOLLOW UP; GENOTYPE; HEPATITIS E; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN A DEFICIENCY; INGESTION; JAUNDICE; LIVER BIOPSY; MALAISE; MALE; MEAT; MORBIDITY; MORTALITY; PHYLOGENY; PORK; PRIORITY JOURNAL; PRURITUS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; WALDENSTROEM MACROGLOBULINEMIA; ACUTE DISEASE; ANIMAL; BLOOD; DRUG EFFECTS; FOOD CONTROL; GENETICS; HEPATITIS E VIRUS; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; PIG; RISK FACTOR; TRANSMISSION; TREATMENT OUTCOME; VIROLOGY; ZOONOSIS;

ACUTE DISEASE; AGED; ANIMALS; ANTIVIRAL AGENTS; BIOMARKERS; FOOD MICROBIOLOGY; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MEAT; PHYLOGENY; RIBAVIRIN; RISK FACTORS; RNA, VIRAL; SWINE; TREATMENT OUTCOME; ZOONOSES;

EID: 84921599589     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000113     Document Type: Article

References (62)

1. WHO. Viral Hepatitis Statement A62/22. Available at: Error! Hyperlink reference not valid. Accessed May 11, 2012.
2. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-Transplant recipients. N Engl J Med. 2008;358:811-817.
3. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-Transplant recipient. N Engl J Med. 2008; 358:859-860.
4. Gerolami R, Moal V, Picard C, et al. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol. 2009;50:622-624.
5. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med. 2010;153:85-89.
6. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481-1489.
7. Halac U, Beland K, Lapierre P, et al. Chronic hepatitis E infection in children with liver transplantation. Gut. 2012;61:597-603.
8. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008;14:547-553.
9. Pischke S, Stiefel P, Franz B, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant. 2012;12:3128-3133.
10. Koning L, Pas SD, de Man RA, et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant. 2013;32:78-85.
11. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology. 2010;139:1612-1618.
12. Chaillon A, Sirinelli A, De Muret A, et al. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant. 2011;30:841-843.
13. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology. 2012;142:1388-1397.
14. Kamar N, Weclawiak H, Guilbeau-Frugier C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation. 2012;93:617-623.
15. Riezebos-Brilman A, Puchhammer-Stockl E, van der Weide HY, et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant. 2013;32:341-346.
16. de Niet A, Zaaijer HL, ten Berge I, et al. Chronic hepatitis E after solid organ transplantation. Neth J Med. 2012;70:261-266.
17. Pischke S, Hardtke S, Bode U, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int. 2013;33:722-726.
18. Colson P, Kaba M, Moreau J, et al. Hepatitis E in an HIV-infected patient. J Clin Virol. 2009;45:269-271.
19. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361:1025-1027.
20. Dalton HR, Keane FE, Bendall R, et al. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med. 2011;155:479-480.
21. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, et al. The Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis. 2011;17:1074-1078.
22. Crum-Cianflone NF, Curry J, Drobeniuc J, et al. Infectious Disease Clinical Research Program HIV Working Group. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis. 2012;18:502-506.
23. Curry JA, Adams N, Crum-Cianflone NF. Acute hepatitis E infection in an HIV-infected person in the United States. Ann Intern Med. 2009;150:226-227.
24. Keane F, Gompels M, Bendall R, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med. 2012;13:83-88.
25. Renou C, Lafeuillade A, Cadranel JF, et al. Hepatitis E virus in HIV-infected patients. AIDS. 2010;24:1493-1499.
26. Madejon A, Vispo E, Bottecchia M, et al. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat. 2009;16:895-896.
27. Jardi R, Crespo M, Homs M, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med. 2012; 13:379-383.
28. Peron JM, Mansuy JM, Recher C, et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol. 2006;21:1223-1224.
29. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res. 2007;37:113-120.
30. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150:430-431.
31. Alric L, Bonnet D, Beynes-Rauzy O, et al. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol. 2011;106:1562-1563.
32. De Silva S, Hassan-Ibrahim MO, Austin M, et al. Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Dig Liver Dis. 2012;44: 930-934.
33. Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298-303.
34. Bouwknegt M, Lodder-Verschoor F, van der Poel WH, et al. Hepatitis E virus RNA in commercial porcine livers in The Netherlands. J Food Prot. 2007;70:2889-2895.
35. Carpentier A, Chaussade H, Rigaud E, et al. High hepatitis E virus seroprevalence in forestry workers and in wild boars in France. J Clin Microbiol. 2012;50:2888-2893.
36. Masuda J, Yano K, Tamada Y, et al. Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res. 2005;31:178-183.
37. Said B, Ijaz S, Kafatos G, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis. 2009;15:1738-1744.
38. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis. 2003;9:448-454.
39. McCreary C, Martelli F, Grierson S, et al. Excretion of hepatitis E virus by pigs of different ages and its presence in slurry stores in the United Kingdom. Vet Rec. 2008;163: 261-265.
40. Jothikumar N, Cromeans TL, Robertson BH, et al. A broadly reactive one-step real-Time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006; 131:65-71.
41. Erker JC, Desai SM, Mushahwar IK. Rapid detection of hepatitis E virus RNA reverse transcription-polymerase chain reaction using universal oligonucleotide primers. J Virol Methods. 1999;81: 109-113.
42. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004;5:113.
43. Stajich JE, Block D, Boulez K, et al. The Bioperl toolkit: Perl modules for the life sciences. Genome Res. 2002;12:1611-1618.
44. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688-2690.
45. Letunic I, Bork P. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 2011;39(Web Server issue):W475-W478.
46. Emerson SU, Arankalle VA, Purcell RH. Thermal stability of hepatitis E virus. J Infect Dis. 2005;192:930-933.
47. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis. 2010; 202:835-844.
48. Tei S, Kitajima N, Takahashi K, et al. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003; 362:371-373.
49. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48:494-503.
50. Zhang S, Wang J, Yuan Q, et al. Clinical characteristics and risk factors of sporadic Hepatitis E in central China. Virol J. 2011;8:152.
51. Schlosser B, Stein A, Neuhaus R, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2012;56:500-502.
52. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-Transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004; 44:934-940.
53. Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74:563-572.
54. Boxall E, Herborn A, Kochethu G, et al. Transfusion-Transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med. 2006;16:79-83.
55. Colson P, Coze C, Gallian P, et al. Transfusion-Associated hepatitis E, France. Emerg Infect Dis. 2007;13:648-649.
56. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-Transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48:1368-1375.
57. Kimura Y, Gotoh A, Katagiri S, et al. Transfusion-Transmitted hepatitis E in a patient with myelodysplastic syndromes. Blood Transfus. 2013;2:1-4.
58. Haim-Boukobza S, Ferey MP, Vetillard AL, et al. Transfusion-Transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol. 2012;57: 1374-1378.
59. Peron JM. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?. J Hepatol. 2011;54:1323-1324.
60. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol. 2011;52:60-62.
61. Del Bello A, Arne-Bes MC, Lavayssiere L, et al. Hepatitis E virus-induced severe myositis. J Hepatol. 2012;57:1152-1153.
62. Goyal R, Kumar A, Panda SK, et al. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther. 2012;17:1091-1096.